Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: Kibong'oto Infectious Diseases Hospital (KIDH)
Street 1: Sanya Juu
Street 2:
City: Kilimanjaro
Province:
Post Code: +255
Country: United Republic of Tanzania
Phone: +255272756754
Email: kisonga2002@yahoo.com
Web Site:

Focal Point Contact Information

Salutation: Dr
First Name: Alexander William
Last Name: Mbuya
Title: Community Medicine Physician
Email: kiletsa@hotmail.com
Phone: +255754812626

Alternate Focal Point Contact Information

Salutation: Dr
First Name: Riziki
Last Name: Kisonga
Title:  
Email: kisonga2002@yahoo.com
Phone:  

General Information

Board Constituency: Countries
Organization Type - Primary: Governmental Organization
Organization Type - Secondary: None
Is your organization legally registered in your country: Yes
Organization Reach: National
Organization Description:
Kibong'oto National Tuberculosis Hospital (KNTH) started as a sanatorium in 1926 and became a national tuberculosis hospital in 1956. Its misson is to provide quality services in the fields of TB, TB/HIV and MDRTB in the country. The main focus is TB and MDRTB services. It also conducts training to health care workers & students and conducts research in collaboration with other intitutions in the above fields of work
Since its establishement, TB has been the core activity of KNTH
Currently the hospital provides inpatients and outpatients services for TB, TB/HIV and MDRTB (it is the national centre for MDRTB) patients (though a small number of patients with other disease conditions are also managed at KNTH). KNTH plans to become an infectious diseases institute, expanding its services by extensively involve the community in the TB control mainly through community education, advocacy and social mobilization. Its also plans to commence contact tracing among MDRTB patients and community active case finding
 
Total number of staff in your organization: 100 +
Number of full-time staff who are directly involved with TB: 100 +
Number of part-time staff who are directly involved with TB: 1 - 5
Number of volunteers who are directly involved with TB: 1 - 5
 
What is your organization's annual budget (USD) dedicated to TB? $1 MIL-$10 MIL
How did you hear about the Stop TB Partnership: Involvement in TB control provision
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Network with other partners
 
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: Yes
Please tell us how your organization is contributing to your country's national TB control plan:
1. Providing diagnostic and treatment services for suspects and TB, TB/HIV and MDRTB for both inpatient and outpatient respectively
2. Working with the National Tuberculosis and Leprosy Programme (NTLP) in conducting trainings on TB, TB/HIV and MDRTB to health care providers in various districts and regions countrywide
3. Working with NTLP to conducting supportive supervisions to health facilities in various districts countrywide
4. Organizing and conducting trainings on MDRTB to District TB and Leprosy coordinators of districts in which MDRTB patients are comming from
5. Yearly participating in World TB Day commemoration, including providing community education and TB and HIV screening
6. Working in collaboration with other institutions on conducting research on TB e.g. on shortening of TB treatment duration
6. Involving the communities in the fight against TB/MDRTB through mass education, sensitisation and TB investigation especially to the most at risk populations like miners and migrants
 

Geographical Reach

Which country is your headquarters located in: United Republic of Tanzania
Which WHO region is the main focus of your work: African
Which countries do you do operate in:
(This includes countries you are conducting activities in)
United Republic of Tanzania

Specializations

Advocacy
Delivery of health services and care
Provision of drugs, diagnostics and commodities
Research and Development
Technical Assistance

Specializations in Countries

Advocacy United Republic of Tanzania
Delivery of health services and care United Republic of Tanzania
Research and Development United Republic of Tanzania

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

TB Care Delivery:
KIDH provide TB treatment under DOT to all its TB patients, providing choices to patients on whether to pursue home based DOT or health facility based DOT.
KIDH is working with other health facilities in the region to conduct community education, sensitisation and TB screening programs, especially among miners populations which are known to be focal points for TB
All TB training programs to health care workers at KIDH and those from outside, includes DOT
In all advocacy activities, including during World TB Day commemorations, the community is educated and emphasized on the importance of DOTS
KIDH is working with an officially formed and registered group of former TB patients in the districts to conduct education on DOTS and the members are involved in all the activities during World TB Day commemoration at the hospital
KIDH hospital provides full inpatients services for all TB patients in re-treatment program so as to ensure fully intake of all the requiried doses
A program on training the MDRTB patients at KIDH on peer education has commenced and in progress

Drug-Resistant TB:
KIDH is currently the sole centre which provides MDRTB services in the country which began in November 2009.
KIDH regularly conduct trainings to district coordinators on the management of MDRTB patients during the continuation phase.

TB-HIV:
KIDH provided TB/HIV services including: counseling and testing for HIV among all TB suspects/ patients, providing cotrimoxazole prophylaxis to all TB/HIV co-infected clients, conducting routine TB screening among all people living with HIV attending Care and Treatment Clinics, providing Isoniazid Preventive Therapy to all HIV clients with no TB, regular education program to HIV clients on TB infection control and providing ARVs to TB/HIV co-infected clients

Laboratory Strengthening:
The laboratory at KIDH utilises multiple technologies for TB diagnosis including: AFB smear microscopy, GeneXpert analysis and sputum culture. The laboratory is a member of the East African Public Health Laboratory Networking Project under the World Bank Project.
The laboratory also performs other general investigations including those related to general management of MDRTB patients

New Diagnostics:
KIDH laboratory is expecting to commence short term liquid culture and drug sensitivity testing (DST) in the near future

Research:
A number of researches have been conducted at KIDH in collaboration with other insitution like the Kilimanjaro Clinical Research Insitute (KCRI), including: shortening of TB treatment duration and TB diagnosis using an overnight pooled sputum

Declaration

Declaration of interests:
No conflicts of interest were delacred.

Application date: March 29, 2013
Last updated: June 16, 2014